Frontiers in Neuroendocrinology (FIN)is comprised of comprehensive review articles, systematic reviews, opinion pieces, and meta-analyses. Most of the reviews are invited but we welcome unsolicited reviews and meta-analyses, and proposals for thematic special issues provided they meet the quality threshold of the journal. We also encourage authors to submit proposals for commentaries which succinctly raise new ideas or provide additional analysis to further explore ramifications of an article published in FIN.
Areas of interest include:
Endocrine interactions that influence neuropsychiatric and neurodegenerative disease
Sex differences in clinical populations and in pre-clinical models
Stress and stress systems interactions with health and disease
Neuroendocrine influences on health across the lifespan from development, puberty, adulthood and aging
Microbiota/neuroendocrine interactions with health and disease
Neuroendocrine -immune interactions: links to behavior and disease
Integrative cellular, molecular and behavioral aspects of hormonally active neuropeptides
Comparative and clinical neuroendocrinology
Neuroendocrine control of energy balance, glucose homeostasis, and metabolism

Editor
L. Galea
The University of British Columbia, Vancouver, British Columbia, Canada
Editorial Board
T. Bale
University of Pennsylvania Department of Psychiatry, Philadelphia, Pennsylvania, United States
S.D. Bilbo
Harvard Medical School, Boston, Massachusetts, United States
J.D. Blaustein
University of Massachusetts Amherst, Amherst, Massachusetts, United States
S. Brummelte
Wayne State University, Detroit, Michigan, United States
E. Choleris
University of Guelph, Guelph, Ontario, Canada
I.J. Clarke
Monash University, Clayton, Victoria, Australia
G. Einstein
University of Toronto, Toronto, Ontario, Canada
J. Elmquist
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, Dallas, Texas, United States
K.M. Frick
University of Wisconsin Milwaukee, Milwaukee, Wisconsin, United States
L-M. Garcia-Segura
Spanish Scientific Research Council, Madrid, Spain
D. Grattan
University of Otago, Dunedin, New Zealand
A. E. Herbison
University of Otago, Dunedin, New Zealand
M.N. Hill
University of Calgary, Calgary, Alberta, Canada
M. Holmes
University of Toronto, Toronto, Ontario, Canada
M. Kawata
Bukkyo University, Kyoto, Japan
K. Kim
Seoul National University School of Biological Sciences, Seoul, Korea, Republic of
E.R. de Kloet
Leiden Amsterdam Centre for Drug Research, Leiden, Netherlands
B. Leuner
OHIO STATE UNIVERSITY, Columbus, Ohio, United States
P. Lucassen
University of Amsterdam, Amsterdam, Netherlands
M.M. McCarthy
University of Maryland School of Medicine, Baltimore, Maryland, United States
C.M. McCormick
Brock University, St Catharines, Ontario, Canada
B.S. McEwen
Rockefeller University, New York, New York, United States
Z. Naor
Tel Aviv University, Tel Aviv, Israel
I. Neumann
University of Regensburg, Regensburg, Germany
D.W. Pfaff
Rockefeller University, New York, New York, United States
T. Plant
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
E. Rissman
University of Virginia School of Medicine, Charlottesville, Virginia, United States
M. Schwartz
University of Washington, Seattle, Washington, United States
M.S. Smith
Oregon Health & Science University Oregon National Primate Research Center, Beaverton, Oregon, United States
F. Sohrabji
Texas A&M University Health Science Center Department of Neuroscience and Experimental Therapeutics, Bryan, Texas, United States
B. Trainor
University of California Davis, Davis, California, United States
A.H. Veenema
Michigan State University, East Lansing, Michigan, United States
J. Verbalis
Georgetown University Medical Center, Washington, District of Columbia, United States
S. Wray
National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, United States
L. Young
Emory University, Atlanta, Georgia, United States